22	Saranjit Singh, Stability Testing During Development of Nanopharmaceuticals, Pharmaceutical Nanotechnology, 3(4): 306-314 (2016).
21	Mallikarjun Narayanam, Tarun Handa, Parul Sharma, Shalu Jhajra, Praveen K Muthe, Pavan K Dappili, Ravi P Shah, Saranjit Singh, Critical Practical Aspects in the Application of Liquid Chromatography- Mass Spectrometric Studies for the Characterization of Impurities and Degradation Products, Journal of Pharmaceutical and Biomedical Analysis, 87 191– 217 (2014).
20	Saranjit Singh, M. Junwal, G. Modhe, H. Tiwari, M. Kurmi, N. Prashar, P. Sidduri, Forced Degradation Studies to Assess the Stability of Drugs and Products, Trends in Analytical Chemistry, 49 71–88 (2013).
19	Saranjit Singh, Tarun Handa, Mallikarjun Narayanam, Archana Sahu, Mahendra Junwal, Ravi P. Shah, A Critical Review on the Use of Modern Sophisticated Hyphenated Tools in Characterization of Impurities and Degradation Products, Journal of Pharmaceutical and Biomedical Analysis, 69, 148-173 (2012).
18	Bhagwat Prasad, Amit Garg, Hardik Takwani and Saranjit Singh, Metabolite Identification by Liquid Chromatography-Mass Spectrometry, Trends in Analytical Chemistry, 30(2), 360-387 (2011).
17	Saranjit Singh, Vikrantsinh M. Gohil, Amandeep Kaur, Bhagwat Prasad, Akash Savaliya and Ravi P. Shah, Strategies for the Characterization of Sildenafil, Vardenafil, Tadalafil and their Analogues in Herbal Preparations, and Detection of Counterfeit Products containing these drugs, Trends in Analytical Chemistry, 28(1), 13-28 (2009).
16	Vijay Kumar, Bhagwat Prasad and Saranjit Singh, Pharmaceutical Issues in the Development of a Polypill for the Treatment of Cardiovascular Diseases, Drug Discovery Today: Therapeutic Strategies, 5(1), 63-71 (2008).
15	M. Gulati, Saranjit Singh, D. Chopra, S. Duggal,  R. Kumar, Use of Liposomal Drugs in the Treatment of Rheumatoid Arthritis, Current Rheumatology Reviews, 4(1) 63-70 (2008).
14	A. Paudel, V. Kumar, and Saranjit Singh, Mass Spectrometry in Pharmaceutical Analysis, Pharmbit, 15 (1), 1-14 (2007).
13	M. Bakshi and Saranjit Singh, Development of Validated Stability-indicating Assay Methods–Critical Review. Journal of Pharmaceutical and Biomedical Analysis, 28(6), 1011-40 (2002).
12	Saranjit Singh, K.V. Rama Rao, K. Venugopal and R. Manikandan, Alteration in Dissolution Characteristic of Gelatin Containing Formulations: A Review of the Problem, Test Methods, and Solutions, Pharmaceutical Technology, 26 (4), 36-58 (2002).
11	Saranjit Singh, T.T. Mariappaan, R. Shankar, N. Sharda and B. Singh, A Critical Review of the Probable Reasons for the Poor Variable Bioavailability of Rifampicin from Anti-tubercular Fixed-dose Combination (FDC) Products, and the Likely Solutions to the Problem. International Journal of Pharmaceutics, 228 (1-2), 5-17(2001).
10	T. Geetha and Saranjit Singh, Applications of Immobilized Artificial Membrane Chromatography–A Potential In Vitro Technique, Pharmaceutical Science and Technology Today, 3 (12), 406-416 (2000).
9	Saranjit Singh and M. Bakshi, Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs, Pharmaceutical Technology Asia, 24-36 (2000).
8	Saranjit Singh and M. Bakshi, Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drugs, Pharmaceutical Technology On-line, 24, 1-14 (2000).
7	M. Grover, M. Bakshi, B. Singh, and Saranjit Singh, Quantitative Structure-Property Relationships in Pharmaceutical Research, Part I, Pharmaceutical Science and Technology Today, 3(1), 28-35(2000).
6	M. Grover, M. Bakshi, B. Singh, and Saranjit Singh, Quantitative Structure-Property Relationships in Pharmaceutical Research, Part II, Pharmaceutical Science and Technology Today, 3(2), 50-57(2000).
5	Saranjit Singh, Stability Testing and Shelf-Life Determination According to International Guidelines, Pharmaceutical Technology Asia, Special issue, November 1999, 14-26.
4	Saranjit Singh, Stability Test Storage Conditions for Zones III and IV: Some Unresolved Issues, Pharmaceutical Technology, 23, 130-142(1999).
3	Saranjit Singh, Stability Testing and Shelf-Life Determination A ccording to International Guidelines, Pharmaceutical Technology, 23, 68-88 (1999).
2	M. Gulati, M. Grover, Saranjit Singh and M. Singh, Lipophilic Drug Derivatives in Liposomes, International Journal of Pharmaceutics, 165, 129-168 (1998).
1	M. Gulati, S. Bajad,  Saranjit Singh, A.J. Ferdous and M. Singh, Development of Liposomal Amphotericin Formulation, Journal of Microencapsulation, 15(2) 137-151(1998).